Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Drugs

Showing results (541-550 of 7,076) with videos related to

Pageof 708
Sort By:
Drugs|December 11, 2003
Clinical pharmacology of proton pump inhibitors: what the practising physician needs to knowMalcolm Robinson, John Horn
Drugs|December 11, 2003
EnfuvirtideToni M Dando, Caroline M Perry
Drugs|October 4, 2003
Pharmacological management of first-episode schizophrenia and related nonaffective psychosesDaniel W Bradford, Diana O Perkins, Jeffrey A Lieberman
Drugs|October 4, 2003
Improving health-related quality of life in gastro-oesophageal reflux diseaseMichael J Shaw, Joseph A Crawley
Drugs|January 14, 2004
Efflux-mediated drug resistance in bacteriaXian-Zhi Li, Hiroshi Nikaido
Drugs|January 1, 1992
Comparative efficacy of antidepressantsS Kasper, J Fuger, H J Möller
Drugs|January 1, 1992
Efficacy of fluvoxamine in severe depressionJ Mendlewicz
Drugs|January 1, 1992
The safety of antidepressantsF de Jonghe, J A Swinkels
Drugs|June 1, 1992
Appetite suppressants. A reviewT Silverstone
Drugs|September 23, 2003
Appropriate empirical antibacterial therapy for nosocomial infections: getting it right the first timeMarin Kollef
Pageof 708

Showing results (541-550 of 7,076) with videos related to

Sort By:
Pageof 708
Drugs|December 11, 2003
Clinical pharmacology of proton pump inhibitors: what the practising physician needs to knowMalcolm Robinson, John Horn
Drugs|December 11, 2003
EnfuvirtideToni M Dando, Caroline M Perry
Drugs|October 4, 2003
Pharmacological management of first-episode schizophrenia and related nonaffective psychosesDaniel W Bradford, Diana O Perkins, Jeffrey A Lieberman
Drugs|October 4, 2003
Improving health-related quality of life in gastro-oesophageal reflux diseaseMichael J Shaw, Joseph A Crawley
Drugs|January 14, 2004
Efflux-mediated drug resistance in bacteriaXian-Zhi Li, Hiroshi Nikaido
Drugs|January 1, 1992
Comparative efficacy of antidepressantsS Kasper, J Fuger, H J Möller
Drugs|January 1, 1992
Efficacy of fluvoxamine in severe depressionJ Mendlewicz
Drugs|January 1, 1992
The safety of antidepressantsF de Jonghe, J A Swinkels
Drugs|June 1, 1992
Appetite suppressants. A reviewT Silverstone
Drugs|September 23, 2003
Appropriate empirical antibacterial therapy for nosocomial infections: getting it right the first timeMarin Kollef
Pageof 708